Search

This text seeks to analyze the privatization guidelines both globally and at the local level and their deployment in public basic education in Brazil. For that, a bibliographic and documentary study was used, using only public domain. It is possible to diagnose the double movement of endo and exoprivatization carried out in the educational panorama of Brazil, especially through the insertion of large business groups, as well as the reforms undertaken to put into operation the privatization agenda of public basic education. It is observed that the insertion of the private sector into the spaces of human formation reverberate metamorphoses, including that of the social function of the school institution, since it incorporates a link with the business and financial logic and, consequently, will facilitate a loss of the public sense of education as a social right.

The globalization of capital implied worldwide consequences, evidencing in the new international division of labor a global imperialist policy in which it is effective through its accumulation by spoliation. Educational policy does not limit its ideological basis only to the local precepts of its National State. From the conjuncture of globalization, the elements that constitute the social patrimony of a nation need to be conferred not only on a local micro-analysis, but a macro analysis is urgent, in which it contemplates the global space-time, thus comprising the interdependent relationship involving central and peripheral countries. Higher education is highlighted in World Bank documents from the 1990s onwards by providing the peripheral National States with four documents outlining strategies to align peripheral higher education policy with the attempts of imperialist states. The understanding of higher education in peripheral countries as a highly profitable niche conceived policies that were and are in line with the rationality of financially-oriented capital. In the Brazilian particularity, this process contributed to the privatization expansion of Higher Education and its consequent commodification.

Copyright of Education Policy Analysis Archives / Archivos Analíticos de Políticas Educativas / Arquivos Analíticos de Políticas Educativas is the property of Educational Policy Analysis Archives & Education Review and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The objective of this study was to evaluate the long-term outcomes of a single institution, Hospital Sírio-Libanes in São Paulo, Brazil, regarding the treatment of peritoneal carcinomatosis. Between October 2002 and October 2006, 46 consecutive patients were treated with radical cytoreduction and hyperthermic peritoneal chemotherapy. There were 21 patients with peritoneal surface malignancy (PSM) from colorectal origin (among whom 8 had an appendiceal primary), 15 with ovarian carcinomas, 2 with primary peritoneal mesotheliomas, and 8 with other cancers. The median age was 49 years (range 18–77 years). All patients were followed for a median of 20 months. Demographic data, tumor histology, the peritoneal carcinomatosis index (PCI), operative procedures (extension of resection, lymphadenectomy), and hyperthermic intraperitoneal chemotherapy (HIPEC) characteristics (drugs, temperature, duration) were prospectively recorded. Perioperative mortality and morbidity and the long-term outcome were assessed. Complete cytoreduction was achieved in 45 patients. The median PCI was 11, and the mean operating time was 17 h. There were no procedure-related deaths, but major morbidity was observed in 52% and included fistulas, abscesses, and hematologic complications. The overall Kaplan–Meier 4-year estimated survival was 56%. Among patients with PSM from colorectal carcinoma, the estimated 3-year survival was 70%. Nine (42%) patients had a recurrence, three with peritoneal disease. The median disease-free-interval was 16 months. The ovarian cancer patients had an estimated 4-year survival rate of 75% and median disease-free survival duration of 21 months. Cytoreductive surgery with HIPEC may improve survival of selected patients with peritoneal carcinomatosis, with acceptable morbidity. [ABSTRACT FROM AUTHOR]

Copyright of Dados - Revista de Ciências Sociais is the property of DADOS and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Purpose: Advanced pancreatic adenocarcinoma (PA) is an aggressive disease that has poor prognosis and frequently interferes with patient's quality of life. There has been progress in first-line regimens; however, there is no standard second-line regimen. The aim of this study is to analyze second-line gemcitabine after first-line fluorouracil (FU) + leucovorin (LV) + irinotecan + oxaliplatin (FOLFIRINOX) regimen., Methods: This study included consecutive patients with advanced PA treated at Hospital Sirio-Libanês from 2011 to 2016. The patients received FOLFIRINOX as first-line treatment and upon progression, received gemcitabine alone. Survival analysis was performed using the Kaplan-Meier method., Results: A total of 54 patients were evaluated. Most patients were male (61.1%) and most had an ECOG performance status of 0 or 1 prior to the beginning of second-line treatment (66.6%). The mean number of gemcitabine cycles was 3.4. Most patients had disease progression as the best response to treatment (75.9%), 11.1% had stable disease, and 9.3% experienced a partial response. The median progression-free survival was 1.7 months, and the median overall survival was 6.8 months., Conclusions: Gemcitabine alone did not show meaningful clinical benefit as second-line treatment after FOLFIRINOX.